Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May;32(5):627-631.
doi: 10.29271/jcpsp.2022.05.627.

Outcomes of Nephron-sparing Surgery in T1 vs T2 Renal Tumours

Affiliations

Outcomes of Nephron-sparing Surgery in T1 vs T2 Renal Tumours

Pardeep Kumar et al. J Coll Physicians Surg Pak. 2022 May.

Abstract

Objective: To compare the drop in eGFR after nephron-sparing surgery in T1 and T2 renal tumours.

Study design: Descriptive study.

Place and duration of study: Department of Uro-oncology, Sindh Institute of Urology, and Transplantation Karachi, from March 2020 to March 2021.

Methodology: Retrospective data were collected for all patients who underwent nephron-sparing surgery between 2014 to 2019. Eighty-seven patients were divided into two groups based on the T stage of renal tumours (T1 ≤7 cm and T2 >7 cm). The outcomes of the two groups were compared such as eGFR, blood transfusion, hospital stay and complications.

Results: There was a higher drop in eGFR in T2 tumours when compared to T1 tumours at 1 year of follow-up. There were more perioperative complications, higher blood transfusions and longer hospital stays for T2 tumours.

Conclusion: Nephron sparing surgery for T2 renal tumours carries lower eGFR preservation, higher blood transfusions and complications when compared to T1 tumours. The indication for such extensive surgery should be individualized to specific contexts only.

Key words: Adenocarcinoma kidney, Nephrectomy, Glomerular filtration rate, Length of hospital stay, Blood transfusion.

PubMed Disclaimer